First Affirmative Financial Network

Position in GILD — Gilead Sciences, Inc.

CIK 1656282 COLORADO SPRINGS, CO

Position in GILD

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$520,546

+$112,954 QoQ

Shares Held

3,735

+1.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.27%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

First Affirmative Financial Network holds $11,800,477 across 12 Drug Manufacturers - General names. GILD ranks #8 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVS	Novartis AG	12,575	$1,920,831
2	JNJ	Johnson & Johnson	7,524	$1,839,166
3	LLY	ELI LILLY & Co	1,848	$1,699,734
4	AZN	Astrazeneca PLC	7,477	$1,474,613
5	MRK	Merck & Co., Inc.	10,609	$1,276,156
6	ABBV	AbbVie Inc.	5,527	$1,202,067
7	AMGN	Amgen Inc	2,302	$809,958
8	GILD	Gilead Sciences, Inc. This page	3,735	$520,546

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$520,546	3,735	+1.7%	Shares	Sole	2026-05-11
2025-09-30	$407,592	3,672	+8.1%	Shares	Sole	2025-11-20
2025-06-30	$376,514	3,396	+1.0%	Shares	Sole	2025-11-20
2025-03-31	$376,600	3,361	-13.7%	Shares	Sole	2025-04-11
2024-12-31	$359,781	3,895	-1.5%	Shares	Sole	2025-01-23
2024-09-30	$331,587	3,955	-15.1%	Shares	Sole	2024-10-10
2024-06-30	$319,722	4,660	+7.3%	Shares	Sole	2024-07-10
2024-03-31	$318,051	4,342	+3.5%	Shares	Sole	2024-04-11
2023-12-31	$339,836	4,195	+22.1%	Shares	Sole	2024-01-08
2023-09-30	$257,568	3,437	+8.6%	Shares	Sole	2023-10-16
2023-06-30	$244,003	3,166	+16.2%	Shares	Sole	2023-07-10
2023-03-31	$226,010	2,724	-0.5%	Shares	Sole	2023-04-11
2022-12-31	$235,057	2,738	-6.5%	Shares	Sole	2023-01-23
2021-12-31	$212,674	2,929	—	Shares	Sole	2022-02-15
No filing history on record for this holder in this stock.